Serum Leucine-Rich α2-Glycoprotein as a Biomarker for Monitoring Disease Activity in Patients with Systemic Juvenile Idiopathic Arthritis
To investigate whether serum leucine-rich α2-glycoprotein (LRG) levels are useful as a marker of disease activity in systemic juvenile idiopathic arthritis (s-JIA), we determined serum LRG levels in fifty-nine s-JIA patients, 15 with other subtypes of JIA, 7 with Kawasaki disease (KD), 7 with influe...
Main Authors: | Masaki Shimizu, Natsumi Inoue, Mao Mizuta, Yasuo Nakagishi, Akihiro Yachie |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2019/3140204 |
Similar Items
-
Leucine‐rich α‐2 glycoprotein is a predictive marker of therapeutic efficacy of the biologics in psoriatic arthritis
by: Yuka Shibata, et al.
Published: (2021-08-01) -
Macrophage activation syndrome in systemic juvenile idiopathic arthritis
by: Masaki Shimizu
Published: (2021-05-01) -
Evaluation of leucine-rich alpha-2 glycoprotein as a biomarker of fetal infection.
by: Etsuko Kajimoto, et al.
Published: (2020-01-01) -
Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
by: Masaki Shimizu, et al.
Published: (2020-01-01) -
Biomarkers of Response to Biologic Therapy in Juvenile Idiopathic Arthritis
by: Varvara Choida, et al.
Published: (2021-02-01)